Concord Biotech Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-10-28
Analyst
USGI
Equibles does not estimate personal net worth.
Divanjan Bhakta is recorded as Analyst at USGI. Divanjan Bhakta has spoken on 1 earnings call across 1 company, most recently for Concord Biotech Limited on October 28, 2026. The companies whose calls Divanjan Bhakta spoke on are classified in the Healthcare sector.
“What will be the effective tax rate for the rest of FY27 and FY28?”
USGI
Analyst
Transcript header (unverified)
Concord Biotech Limited
Biotechnology · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Concord Biotech Limited